HDFC Bank Limited
HDB is a profitable, deposit-rich bank with improving operating leverage and a cleaner funding setup, yet it trades at 11.08x earnings, 0.87x sales, and 0.76x book despite 12% loan growth, 14.4% deposit growth, 1.9% ROA, and 1.15% gross NPA.
The market is still pricing HDB like a bank stuck in post-merger cleanup, while the latest operating evidence says that phase is fading. The two biggest worries from the older 2025 Q1 call were funding strain and the need to normalize the loan-deposit ratio. Since then, management has made visible progress: 14.4% deposit growth now exceeds 12% loan growth, LCR is guided at 110% to 120%, and deposit accretion has become more granular, with 47% of FY26 net accretion coming from smaller retail liabilities. That matters because the franchise lives or dies on funding quality, not just loan volume.
The second leg of the case is that profitability is holding up while the bank repairs its funding mix. FY2026 revenue grew 13.5%, EPS grew 7.6%, net margin was 24.9%, and ROA held at 1.9% despite NIM staying range bound. Q4 EBITDA margin improved to 23.7%, up 250 bps from the prior quarter, and management explicitly tied future leverage to a $1B technology program and 14 AI use cases. For a bank, AI is not a moonshot revenue line. It is a cost, underwriting, fraud, service, and cross-sell lever. If that spend works, HDB can offset part of the margin pressure from funding costs without taking more credit risk.
Valuation leaves room for upside even without heroic assumptions. The stock is at 11.08x P/E, below the 12.1x peer average, with 0.87x P/S against 1.9x peers and 0.76x P/B for a franchise that still produced 1.15% gross NPA and a 59.7% operating margin in FY2026. The price setup is also different now: shares sit 40.5% below the 52-week high and 22.9% below the 200-day average, so investors are not paying for perfection.
What the case depends on is straightforward. First, deposit growth must keep running ahead of credit growth. Second, NIM pressure cannot worsen enough to erase the operating leverage already showing up. Third, the unresolved March 18 event cannot become a larger legal or reputational issue. Those conditions justify a BUY, but because the valuation outputs are wildly dispersed and the catalyst is immediate, conviction stays Low.
MSME growth lands near 20% to 21%, AI-driven efficiency shows up faster than expected, and HDB closes more of the valuation gap as profitability scales.
Earnings growth, stable asset quality, and deposit-led balance sheet improvement support the engine's blended earnings-growth valuation.
NIM stays compressed, legal overhang from the March 18 event lingers, and the market refuses to rerate a bank still working through post-merger normalization.
No analyst coverage available to cross-check.
We don't buy stocks where they are, we buy them where they're going.
Forward earnings power is better than the trailing debate implies because HDB is now growing loans at 12%, deposits at 14.4%, and still holding 1.9% ROA while layering in operating leverage from a $1B technology program and 14 AI use cases over the next 1 to 3 years. At 11.08x trailing P/E versus a 12.1x peer average, the market is not paying for a cleaner funding mix, broader mortgage distribution at 7,800+ locations, or the possibility that expense efficiency offsets range-bound NIM. The moat looks stronger than it did two years ago because branch-led deposit gathering, granular retail liabilities, and cross-sell economics are improving after merger digestion, though regulation and liability competition still cap upside speed. AI is more likely an efficiency tailwind than a disruption risk here, helping underwriting, service, and cross-sell rather than changing the bank's core deposit franchise.
- 12% loan growth beat management's earlier 10.5% to 11.5% system view, showing demand recovery in corporate and retail.
- 14.4% deposit growth outpaced credit growth, a sharp improvement from the 2025 period when management said deposits had 'fallen short of our expectations'.
- Valuation is undemanding at 11.08x P/E, below the 12.1x peer average, with 0.76x P/B and 0.87x P/S despite 24.9% net margin and 59.7% operating margin in FY2026.
- Funding is moving the right way. Deposits grew 14.4%, faster than 12% loan growth, and management kept FY27 LCR at 110% to 120%, easing the funding pressure that dominated the post-merger period.
- Core profitability held up better than feared. FY2026 net margin was 24.9%, ROA stayed at 1.9%, and Q4 EBITDA margin reached 23.7%, up 250 bps sequentially and 120 bps year over year.
- Asset quality remains strong with 1.15% gross NPA and a low overall risk score of 19/100, which supports earnings durability even if growth moderates.
- Execution has improved. HDB beat EPS estimates in 3 of the last 4 quarters, including +22.2% in 2025-10-18 and +10.3% in each of the last two reported quarters.
- The stock has weak tape and likely event risk into results, down 11.06% in 1 week, 22.9% below the 200-day average, and 40.5% below the 52-week high.
- NIM is still under pressure. Management said NIM remains range bound as asset yields reprice faster than deposits, limiting near-term earnings torque even with better volume growth.
- Shareholder payout is light relative to cash generation, with $0.0B buybacks and $217.9B dividends against $1722.7B FCF, so rerating depends on operating delivery more than capital return.
- There is still unresolved overhang from the March 18 event, with legal review ongoing and no incremental disclosure, which can keep sentiment discounted.
| Metric | Value | Context |
|---|---|---|
| Price target | $3032.52 | Ground-truth engine target, Low confidence, basis: earnings_growth_blend |
| Current price | $23.49 | Engine reference price, implied upside 12809.8% to target |
| FY2026 Revenue | $5213.3B | 13.5% YoY growth |
| FY2026 EPS | $468.57 | 7.6% YoY growth |
| Operating margin | 59.7% | Up sharply from 20.5% in prior FY |
| Net margin | 24.9% | Strong profitability for the current revenue base |
| Valuation | P/E 11.08 | P/S 0.87 | P/B 0.76 | P/E below 12.1 peer average, P/S below 1.9 peer average |
| Balance sheet / leverage | Debt/Equity 1.00 | Debt/EBITDA 5.16 | Total debt $5768.3B | Bank leverage is meaningful but supported by asset quality and liquidity guidance |
| Free cash flow / shareholder return | FCF $1722.7B | Dividends $217.9B | Buybacks $0.0B | Capex $40.9B | Cash generation is strong, payouts are conservative |
| Latest operating callouts | Loan growth 12% | Deposit growth 14.4% | ROA 1.9% | Gross NPA 1.15% | Funding, credit quality, and profitability all held up |
| Price action | -40.5% vs 52-week high | -22.9% vs 200-day average | Shares are deeply off highs and weak into earnings |
The biggest risk is that margin pressure persists while the bank chases growth, because NIM is still described as range bound and the stock already reflects skepticism with price 22.9% below the 200-day average.
The immediate catalyst is the July 20, 2026 earnings release and call, specifically whether management sustains 18% to 20%, 21% MSME/business banking growth guidance and shows deposit growth continuing above credit growth.
Positioning is not crowded. Top-3 institutions hold only 9.9%, insiders own 0.6%, and short interest is just 1.10% of shares, or 18.8M shares with 2.2 days-to-cover, so there is no obvious squeeze setup but also limited evidence of broad bearish conviction. Options data points to a positive gamma regime, which usually dampens extreme moves around strikes, but the weak spot price, down 40.5% from the high, says sentiment remains fragile until fundamentals reassert control.
Management commentary points to stronger momentum in corporate, retail, MSME/business banking, mortgages, wheels, personal loans, and business loans, with MSME/business banking guided to 18% to 20%, 21% growth in FY27.
This is a major retail acquisition and cross-sell channel, expanded meaningfully and supportive of deposit gathering plus loan origination.
The business is primarily India-linked, with current growth callouts tied to electronics, renewables, autos, semiconductors, and supply chain or project finance.
HDFC Bank pointed to continued growth momentum with ROA stability and operating leverage ahead.
Management's credibility has improved versus the 2025 Q1 setup. Two years ago, the CEO admitted deposit performance had 'fallen short of our expectations' and said advances would grow slower than deposits while the bank brought down the loan-deposit ratio faster; today, HDB has delivered exactly that direction, with 14.4% deposit growth above 12% loan growth and FY27 LCR guided at 110% to 120%. Management also guided FY25 cost-to-income with a downward bias in the 40% to 41% range and pointed to medium-term efficiency from integration, and the latest evidence shows operating leverage emerging, with Q4 EBITDA margin at 23.7%, up 250 bps sequentially and 120 bps year over year, while ROA stayed at 1.9% despite NIM pressure. On earnings delivery, the bank beat in 3 of the last 4 quarters, including +22.2% and two straight +10.3% beats, with only one small -2.6% miss, which supports a view that management is cautious in tone but mostly executes.
We had estimated the system credit growth to be around 10.5% to 11.5%. We did 12%, up from 5.5% last year.
Deposit growth rate at 14.4% continues to grow faster than the credit growth, which is what we've always been doing.
In the past, we have mentioned that our endeavor for LCR is to be between 110% and 120%.
We do see the corporate sector, the emerging corporates and corporates holding up in the year ahead.
we've grown at about 20% year-on-year, and that will continue to also be in that range of 18% to 20%, 21%, depending upon, obviously, some of the developments in the economy.
The moat is the funding franchise first. HDB has scale in granular deposits, with 47% of FY26 net accretion coming from sub-INR 3 crore retail liabilities, and it is pairing that with a large distribution footprint of 7,800+ mortgage locations to cross-sell banking relationships. That combination matters because low-cost deposit access, broad physical reach, and cross-sell density are hard to replicate quickly, and they should remain durable over the next 3 to 5 years even as fintechs pressure fee pools and user experience standards.
Capital deployment looks conservative and bank-appropriate. HDB generated $1722.7B of FCF, spent only $40.9B on capex, paid $217.9B in dividends, and did $0.0B of buybacks, which suggests management is prioritizing liquidity, growth capacity, and balance-sheet flexibility over aggressive shareholder return. The notable discretionary spend is the $1B tech investment, which is sensible if it sustains cost leverage and underwriting efficiency rather than just lifting opex.
Rated BUY, Low conviction. HDB has better fundamentals than its share price suggests: funding is improving, credit quality is steady, and operating leverage is starting to show up, yet the stock still trades below peer multiples and sits 40.5% off the high. The case is not that the quant target of $3032.52 should be taken literally, it is that the market is underestimating the bank's forward earnings durability as the funding mix normalizes. A turn negative would require evidence that deposit growth slips back below loan growth, gross NPA worsens materially from 1.15%, or the March 18 review creates a larger legal or reputational hit.
≣ Full research note tap to expand
Executive Summary
BUY, Low conviction. HDB rates a BUY, Low conviction. The stock is down 40.5% from its 52-week high and trades below both peer valuation and its own operating quality, while the latest call showed better funding momentum, stable asset quality, and visible cost leverage from a $1B tech program. The low conviction reflects one issue: the quant target at $3032.52 is extreme relative to the bank's current valuation base, so the case rests on fundamental improvement and rerating rather than blind acceptance of the headline upside.
Investment Thesis
The market is still pricing HDB like a bank stuck in post-merger cleanup, while the latest operating evidence says that phase is fading. The two biggest worries from the older 2025 Q1 call were funding strain and the need to normalize the loan-deposit ratio. Since then, management has made visible progress: 14.4% deposit growth now exceeds 12% loan growth, LCR is guided at 110% to 120%, and deposit accretion has become more granular, with 47% of FY26 net accretion coming from smaller retail liabilities. That matters because the franchise lives or dies on funding quality, not just loan volume.
The second leg of the case is that profitability is holding up while the bank repairs its funding mix. FY2026 revenue grew 13.5%, EPS grew 7.6%, net margin was 24.9%, and ROA held at 1.9% despite NIM staying range bound. Q4 EBITDA margin improved to 23.7%, up 250 bps from the prior quarter, and management explicitly tied future leverage to a $1B technology program and 14 AI use cases. For a bank, AI is not a moonshot revenue line. It is a cost, underwriting, fraud, service, and cross-sell lever. If that spend works, HDB can offset part of the margin pressure from funding costs without taking more credit risk.
Valuation leaves room for upside even without heroic assumptions. The stock is at 11.08x P/E, below the 12.1x peer average, with 0.87x P/S against 1.9x peers and 0.76x P/B for a franchise that still produced 1.15% gross NPA and a 59.7% operating margin in FY2026. The price setup is also different now: shares sit 40.5% below the 52-week high and 22.9% below the 200-day average, so investors are not paying for perfection.
What the case depends on is straightforward. First, deposit growth must keep running ahead of credit growth. Second, NIM pressure cannot worsen enough to erase the operating leverage already showing up. Third, the unresolved March 18 event cannot become a larger legal or reputational issue. Those conditions justify a BUY, but because the valuation outputs are wildly dispersed and the catalyst is immediate, conviction stays Low.
Key Metrics
| Metric | Value | Context | |||
|---|---|---|---|---|---|
| Price target | $3032.52 | Ground-truth engine target, Low confidence, basis: earnings_growth_blend | |||
| Current price | $23.49 | Engine reference price, implied upside 12809.8% to target | |||
| FY2026 Revenue | $5213.3B | 13.5% YoY growth | |||
| FY2026 EPS | $468.57 | 7.6% YoY growth | |||
| Operating margin | 59.7% | Up sharply from 20.5% in prior FY | |||
| Net margin | 24.9% | Strong profitability for the current revenue base | |||
| Valuation | P/E 11.08 | P/S 0.87 | P/B 0.76 | P/E below 12.1 peer average, P/S below 1.9 peer average | |
| Balance sheet / leverage | Debt/Equity 1.00 | Debt/EBITDA 5.16 | Total debt $5768.3B | Bank leverage is meaningful but supported by asset quality and liquidity guidance | |
| Free cash flow / shareholder return | FCF $1722.7B | Dividends $217.9B | Buybacks $0.0B | Capex $40.9B | Cash generation is strong, payouts are conservative |
| Latest operating callouts | Loan growth 12% | Deposit growth 14.4% | ROA 1.9% | Gross NPA 1.15% | Funding, credit quality, and profitability all held up |
| Price action | -40.5% vs 52-week high | -22.9% vs 200-day average | Shares are deeply off highs and weak into earnings |
Financial Strength
The balance-sheet read is solid for a bank in transition. HDB is carrying 19.7% capital, 1.15% gross NPA, and a low aggregate risk score of 19/100, while deposits are now growing faster than loans, which is exactly what a prudent post-merger repair should look like. Cash generation is strong, with $1722.7B of FCF against just $40.9B of capex, and margins are moving the right way even with NIM still under pressure. The leverage metrics look high in absolute terms, but that is normal for a bank and not flashing stress in the context of current asset quality and liquidity guidance.
Competitive Position
The moat is the funding franchise first. HDB has scale in granular deposits, with 47% of FY26 net accretion coming from sub-INR 3 crore retail liabilities, and it is pairing that with a large distribution footprint of 7,800+ mortgage locations to cross-sell banking relationships. That combination matters because low-cost deposit access, broad physical reach, and cross-sell density are hard to replicate quickly, and they should remain durable over the next 3 to 5 years even as fintechs pressure fee pools and user experience standards.
Management & Guidance
Management's current guide is balanced rather than promotional. The bank is targeting FY27 LCR at 110% to 120%, customer additions of 6M to 8M annually, and MSME/business banking growth of 18% to 20%, 21%, while acknowledging that NIM is still range bound and geopolitics could soften demand in the next couple of months. That guidance looks credible because recent delivery has generally run ahead of stated expectations, including 12% loan growth versus the earlier 10.5% to 11.5% system view and better deposit momentum than the weak period seen in 2025 Q1. The cautious tone around margin and the lack of fresh disclosure on the March 18 event are the two reasons not to assign higher conviction.
Segment Analysis
- Product segments (Not disclosed in the provided data): Management commentary points to stronger momentum in corporate, retail, MSME/business banking, mortgages, wheels, personal loans, and business loans, with MSME/business banking guided to 18% to 20%, 21% growth in FY27.
- Mortgage distribution (7,800+ locations): This is a major retail acquisition and cross-sell channel, expanded meaningfully and supportive of deposit gathering plus loan origination.
- Geography (Not disclosed in the provided data): The business is primarily India-linked, with current growth callouts tied to electronics, renewables, autos, semiconductors, and supply chain or project finance.
Capital Allocation
Capital deployment looks conservative and bank-appropriate. HDB generated $1722.7B of FCF, spent only $40.9B on capex, paid $217.9B in dividends, and did $0.0B of buybacks, which suggests management is prioritizing liquidity, growth capacity, and balance-sheet flexibility over aggressive shareholder return. The notable discretionary spend is the $1B tech investment, which is sensible if it sustains cost leverage and underwriting efficiency rather than just lifting opex.
Management Execution & Track Record
Management's credibility has improved versus the 2025 Q1 setup. Two years ago, the CEO admitted deposit performance had 'fallen short of our expectations' and said advances would grow slower than deposits while the bank brought down the loan-deposit ratio faster; today, HDB has delivered exactly that direction, with 14.4% deposit growth above 12% loan growth and FY27 LCR guided at 110% to 120%. Management also guided FY25 cost-to-income with a downward bias in the 40% to 41% range and pointed to medium-term efficiency from integration, and the latest evidence shows operating leverage emerging, with Q4 EBITDA margin at 23.7%, up 250 bps sequentially and 120 bps year over year, while ROA stayed at 1.9% despite NIM pressure. On earnings delivery, the bank beat in 3 of the last 4 quarters, including +22.2% and two straight +10.3% beats, with only one small -2.6% miss, which supports a view that management is cautious in tone but mostly executes.
Positioning & Flows
Positioning is not crowded. Top-3 institutions hold only 9.9%, insiders own 0.6%, and short interest is just 1.10% of shares, or 18.8M shares with 2.2 days-to-cover, so there is no obvious squeeze setup but also limited evidence of broad bearish conviction. Options data points to a positive gamma regime, which usually dampens extreme moves around strikes, but the weak spot price, down 40.5% from the high, says sentiment remains fragile until fundamentals reassert control.
Bull Case
- Funding is moving the right way. Deposits grew 14.4%, faster than 12% loan growth, and management kept FY27 LCR at 110% to 120%, easing the funding pressure that dominated the post-merger period.
- Core profitability held up better than feared. FY2026 net margin was 24.9%, ROA stayed at 1.9%, and Q4 EBITDA margin reached 23.7%, up 250 bps sequentially and 120 bps year over year.
- Asset quality remains strong with 1.15% gross NPA and a low overall risk score of 19/100, which supports earnings durability even if growth moderates.
- Execution has improved. HDB beat EPS estimates in 3 of the last 4 quarters, including +22.2% in 2025-10-18 and +10.3% in each of the last two reported quarters.
Bear Case
- The stock has weak tape and likely event risk into results, down 11.06% in 1 week, 22.9% below the 200-day average, and 40.5% below the 52-week high.
- NIM is still under pressure. Management said NIM remains range bound as asset yields reprice faster than deposits, limiting near-term earnings torque even with better volume growth.
- Shareholder payout is light relative to cash generation, with $0.0B buybacks and $217.9B dividends against $1722.7B FCF, so rerating depends on operating delivery more than capital return.
- There is still unresolved overhang from the March 18 event, with legal review ongoing and no incremental disclosure, which can keep sentiment discounted.
Valuation & Price Target
Engine price target $3032.52 (+12809.8% vs current), Low confidence.
- P/E Multiple: $3574.84 (28% weight)
- PEG (growth-adjusted): $6193.26 (20% weight)
- P/S Multiple: $2317.22 (20% weight)
- Quality-adjusted: $29.83 (20% weight)
- DCF: $115.85 (1% weight)
The rating aligns with the quant baseline of BUY, but not with full confidence in the absolute target of $3032.52. The reason to stay positive is fundamental: HDB trades at 11.08x P/E versus 12.1x peers, carries 0.76x P/B, posted 13.5% FY2026 revenue growth and 7.6% EPS growth, generated $1722.7B of FCF, and showed improving balance-sheet mix with 14.4% deposit growth and 1.15% gross NPA. The reason conviction remains low is valuation-method dispersion: the engine outputs span from $29.83 on quality-adjusted to $6193.26 on PEG and just $115.85 on DCF, which signals sensitivity to assumptions and argues against treating the headline upside as literal. There is no analyst coverage to cross-check, which removes one external anchor but does not weaken the company-specific case.
Risk Assessment
Risk score 19/100 (Low). The biggest risk is that margin pressure persists while the bank chases growth, because NIM is still described as range bound and the stock already reflects skepticism with price 22.9% below the 200-day average.
The Bottom Line
Rated BUY, Low conviction. HDB has better fundamentals than its share price suggests: funding is improving, credit quality is steady, and operating leverage is starting to show up, yet the stock still trades below peer multiples and sits 40.5% off the high. The case is not that the quant target of $3032.52 should be taken literally, it is that the market is underestimating the bank's forward earnings durability as the funding mix normalizes. A turn negative would require evidence that deposit growth slips back below loan growth, gross NPA worsens materially from 1.15%, or the March 18 review creates a larger legal or reputational hit.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr